Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tubulin inhibitor 41 (Compd D19) is a promising lead compound for glioblastoma treatment, known for its ability to penetrate the blood-brain barrier (BBB). It functions as a tubulin inhibitor, inducing G2/M phase arrest, leading to cell apoptosis, and inhibiting the migration of U87 cells [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Tubulin inhibitor 41 (Compd D19) is a promising lead compound for glioblastoma treatment, known for its ability to penetrate the blood-brain barrier (BBB). It functions as a tubulin inhibitor, inducing G2/M phase arrest, leading to cell apoptosis, and inhibiting the migration of U87 cells [1]. |
In vitro | Tubulin inhibitor 41 (Compd D19) demonstrates significant antiproliferative activity against the U87 cancer cell line (IC 50 = 0.90 ± 0.03 μM) and is capable of degrading the intracellular microtubule cytoskeleton [1]. |
In vivo | Tubulin inhibitor 41 (Compd D19, at doses of 5 mg/kg and 10 mg/kg) suppresses tumor growth in the orthotopic glioma xenograft model (GL261-Luc) in a dose-dependent manner and significantly extends the survival of mice. |
Molecular Weight | 313.35 |
Formula | C20H15N3O |
Cas No. | 2770273-12-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.